High-fidelity target sequencing of individual molecules identified using barcode sequences: De novo detection and absolute quantitation of mutations in plasma cell-free DNA from cancer patients

DNA Research

Volumn 22, Issue 4, 2015, Pages 269-277

  Kukita, Yoji ^a   Matoba, Ryo ^b   Uchida, Junji ^a   Hamakawa, Takuya ^a,c   Doki, Yuichiro ^c   Imamura, Fumio ^a   Kato, Kikuya ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b DNA CHIP RESEARCH INC   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

barcode sequences; circulating tumour DNA; massively parallel DNA sequencer

Indexed keywords

CHLOROPLAST DNA; DNA; DNA POLYMERASE; GENOMIC DNA; RESTRICTION ENDONUCLEASE; TAQ POLYMERASE; TRANSCRIPTOME;

ALLELE; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER GENETICS; CANCER PATIENT; DNA BARCODING; DNA SEQUENCE; HUMAN; HUMAN GENOME; INDEL MUTATION; LUNG CANCER; NONHUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; PLASMA CELL; POLYMERASE CHAIN REACTION; QUANTITATIVE GENETICS; STOMACH CANCER; TUMOR VOLUME; GENETICS; HIGH THROUGHPUT SEQUENCING; LUNG TUMOR; MALE; METABOLISM; MUTATION; NEOPLASM; PROCEDURES; REPRODUCIBILITY; STOMACH TUMOR;

DNA BARCODING, TAXONOMIC; DNA, NEOPLASM; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; NEOPLASMS; PLASMA CELLS; REPRODUCIBILITY OF RESULTS; STOMACH NEOPLASMS;

EID: 84939561586     PISSN: 13402838     EISSN: 17561663     Source Type: Journal    
DOI: 10.1093/dnares/dsv010     Document Type: Article

References (33)

1. Diehl, F., Schmidt, K., Choti, M.A., et al. 2008, Circulating mutant DNA to assess tumor dynamics, Nat. Med., 14, 985-90.
2. Diaz, L.A. Jr., Williams, R.T., Wu, J., et al. 2012, The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers, Nature, 486, 537-40.
3. Misale, S., Yaeger, R., Hobor, S., et al. 2012, Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer, Nature, 486, 532-6.
4. Taniguchi, K., Uchida, J., Nishino, K., et al. 2011, Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas, Clin. Cancer. Res., 17, 7808-15.
5. Burrell, R.A., McGranahan, N., Bartek, J. and Swanton, C. 2013, The causes and consequences of genetic heterogeneity in cancer evolution, Nature, 501, 338-45.
6. Newman, A.M., Bratman, S.V., To, J., et al. 2014, An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage, Nat. Med., 20, 548-54.
7. Lo, Y.M., Zhang, J., Leung, T.N., Lau, T.K., Chang, A.M. and Hjelm, N.M. 1999, Rapid clearance of fetal DNA from maternal plasma, Am. J. Hum. Genet., 64, 218-24.
8. Vogelstein, B. and Kinzler, K.W. 1999, Digital PCR, Proc. Natl Acad. Sci. USA, 96, 9236-41.
9. Bettegowda, C., Sausen, M., Leary, R.J., et al. 2014, Detection of circulating tumor DNA in early- and late-stage human malignancies, Sci. Transl. Med., 6, 224ra224.
10. Dawson, S.J., Tsui, D.W., Murtaza, M., et al. 2013, Analysis of circulating tumor DNA to monitor metastatic breast cancer, N. Engl. J. Med., 368, 1199-209.
11. Casbon, J.A., Osborne, R.J., Brenner, S. and Lichtenstein, C.P. 2011, A method for counting PCR template molecules with application to nextgeneration sequencing, Nucleic Acids Res., 39, e81.
12. Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K.W. and Vogelstein, B. 2011, Detection and quantification of rare mutations with massively parallel sequencing, Proc. Natl Acad. Sci. USA, 108, 9530-5.
13. Hamady, M., Walker, J.J., Harris, J.K., Gold, N.J. and Knight, R. 2008, Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex, Nat. Methods, 5, 235-7.
14. Shiroguchi, K., Jia, T.Z., Sims, P.A. and Xie, X.S. 2012, Digital RNA sequencing minimizes sequence-dependent bias and amplification noise with optimized single-molecule barcodes, Proc. Natl Acad. Sci. USA, 109, 1347-52.
15. Berrozpe, G., Schaeffer, J., Peinado, M.A., Real, F.X. and Perucho, M. 1994, Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer, Int. J. Cancer, 58, 185-91.
16. Kukita, Y., Uchida, J., Oba, S., et al. 2013, Quantitative identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing data, PLoS ONE, 8, e81468.
17. Li, H. and Durbin, R. 2010, Fast and accurate long-read alignment with Burrows-Wheeler transform, Bioinformatics, 26, 589-95.
18. Li, H., Handsaker, B., Wysoker, A., et al. 2009, The Sequence Alignment/ Map format and SAMtools, Bioinformatics, 25, 2078-9.
19. Koboldt, D.C., Zhang, Q., Larson, D.E., et al. 2012, VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing, Genome Res., 22, 568-76.
20. Schmitt, M.W., Kennedy, S.R., Salk, J.J., Fox, E.J., Hiatt, J.B. and Loeb, L. A. 2012, Detection of ultra-rare mutations by next-generation sequencing, Proc. Natl Acad. Sci. USA, 109, 14508-13.
21. Iwao-Koizumi, K., Maekawa, K., Nakamura, Y., et al. 2007, A novel technique for measuring variations in DNA copy-number: competitive genomic polymerase chain reaction, BMC Genomics, 8, 206.
22. Kato, K. 1997, Adaptor-tagged competitive PCR: a novel method for measuring relative gene expression, Nucleic Acids Res., 25, 4694-6.
23. Kato, K., Yamashita, R., Matoba, R., et al. 2005, Cancer gene expression database (CGED): a database for gene expression profiling with accompanying clinical information of human cancer tissues, Nucleic Acids Res., 33, D533-6.
24. Kato, K. 1995, Description of the entire mRNA population by a 3′ end cDNA fragment generated by class IIS restriction enzymes, Nucleic Acids Res., 23, 3685-90.
25. Hiatt, J.B., Pritchard, C.C., Salipante, S.J., O'Roak, B.J. and Shendure, J. 2013, Single molecule molecular inversion probes for targeted, highaccuracy detection of low-frequency variation, Genome Res., 23, 843-54.
26. Quail, M.A., Smith, M., Coupland, P., et al. 2012, A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers, BMC Genomics, 13, 341.
27. Junemann, S., Sedlazeck, F.J., Prior, K., et al. 2013, Updating benchtop sequencing performance comparison, Nat. Biotechnol., 31, 294-6.
28. Couraud, S., Vaca-Paniagua, F., Villar, S., et al. 2014, Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/ IFCT-1002, Clin. Cancer Res., 20, 4613-24.
29. Shigemitsu, K., Sekido, Y., Usami, N., et al. 2001, Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion, Oncogene, 20, 4249-57.
30. Kris, M.G., Johnson, B.E., Berry, L.D., et al. 2014, Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs, JAMA, 311, 1998-2006.
31. Deakin, C.T., Deakin, J.J., Ginn, S.L., et al. 2014, Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequence, Nucleic Acids Res., 42, e129.
32. Forshew, T., Murtaza, M., Parkinson, C., et al. 2012, Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA, Sci. Transl. Med., 4, 136ra168.
33. Narayan, A., Carriero, N.J., Gettinger, S.N., et al. 2012, Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing, Cancer Res., 72, 3492-8.